Phase II trial of an ointment formulation of NF-kappa-B decoy oligonucleotide in Japan for the treatment of atopic dermatitis.
Phase of Trial: Phase II
Latest Information Update: 03 Oct 2014
At a glance
- Drugs NF kappa B Decoy-AnGes MG (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; Therapeutic Use
- 03 Oct 2014 New trial record